Metraipolis › archive › dc_d4e9577f1313

Multi-Omics Tumor Immunogenicity Score Predicts Immunotherapy Outcome and Survival — Europe PMC PMID:41463470

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41463470
DOI
10.3390/biology14121698
License (as archived)
solo-consultazione
Archived
2026-11-08T04:43:37.670Z
SHA-256 of the archived text
f5bd711a2310aa4869d8ee65b19d2b25f1b9360b7a2b9bc38c5d70ac46f1901d
Stable URL of this page
https://metraipolis.com/documento/dc_d4e9577f1313

How to cite

Multi-Omics Tumor Immunogenicity Score Predicts Immunotherapy Outcome and Survival — Europe PMC PMID:41463470 — Europe PMC (en), https://europepmc.org/article/MED/41463470 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d4e9577f1313 (Metraipolis archive dc_d4e9577f1313, sha256 f5bd711a2310aa4869d8ee65b19d2b25f1b9360b7a2b9bc38c5d70ac46f1901d)
BibTeX
@misc{dcd4e9577f1313,
  title = {Multi-Omics Tumor Immunogenicity Score Predicts Immunotherapy Outcome and Survival — Europe PMC PMID:41463470},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41463470},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d4e9577f1313; sha256 f5bd711a2310aa4869d8ee65b19d2b25f1b9360b7a2b9bc38c5d70ac46f1901d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41463470. Agents can read the archived copy with the MCP tool read_document.